Genomic sequencing of a national emm66 group A streptococci (GAS) outbreak among people who inject drugs and the homeless community in England and Wales, January 2016-May 2017.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
11 2019
Historique:
received: 07 08 2018
revised: 09 08 2019
accepted: 11 08 2019
pubmed: 17 8 2019
medline: 17 7 2020
entrez: 17 8 2019
Statut: ppublish

Résumé

An outbreak of an uncommon emm type (emm66.0) of group A streptococcus (GAS) occurred in England and Wales between January 2016 and May 2017, involving 52 individuals who were homeless or injecting drugs users. In order to investigate the outbreak, epidemiological and network analysis were performed; moreover 55 isolates (32 outbreak, 5 non-outbreak and 13 historical - 2005-2015) were tested with whole genome sequencing (WGS), antimicrobial resistance determination, Bayesian evolutionary analysis (BEAST). Forty one isolates (including 32 outbreak strains) belonged to a single emm66.0 clade (average SNP difference 6.6; range 0-16 SNPs) separate from the other isolates and two strains previously considered part of the outbreak (SNP average: 5876; range 93-8417 SNPs). Antibiotic resistance was not detected in the outbreak clone. No common source of infection was identified. WGS confirmed expansion of an emm66.0 clone in a hard-to-reach population and enabled refinement of the initial case definition.

Identifiants

pubmed: 31419474
pii: S0163-4453(19)30249-X
doi: 10.1016/j.jinf.2019.08.009
pii:
doi:

Substances chimiques

Antigens, Bacterial 0
Bacterial Outer Membrane Proteins 0
Carrier Proteins 0
streptococcal M protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-443

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Laura Bubba (L)

Bacteriology Reference Department, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK; European Programme for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Gustav III:s boulevard 40, 169 73 Solna, Stockholm, Sweden. Electronic address: laura.bubba@phe.gov.uk.

Nick Bundle (N)

United Kingdom Field Epidemiology Training Programme, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK; Field Epidemiology Services, National Infection Service, Public Health England, Wellington, Waterloo Rd, Lambeth, London SE1 8UG, London, UK.

Georgia Kapatai (G)

Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Roger Daniel (R)

Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Sooria Balasegaram (S)

United Kingdom Field Epidemiology Training Programme, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Charlotte Anderson (C)

United Kingdom Field Epidemiology Training Programme, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Vicki Chalker (V)

Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Theresa Lamagni (T)

Healthcare-Associated Infection & Antimicrobial Resistance Department, National Infection Service, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Colin Brown (C)

Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Derren Ready (D)

Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Androulla Efstratiou (A)

Bacteriology Reference Department, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Juliana Coelho (J)

Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England, 61 Colindale Avenue, NW9 5EQ London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH